review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.VASCN.2015.05.011 |
P698 | PubMed publication ID | 26045062 |
P2093 | author name string | Joshua D Yoder | |
David V Gauvin | |||
Jill A Dalton | |||
Theodore J Baird | |||
Matthew M Abernathy | |||
Rachel L Tapp | |||
P2860 | cites work | Neural generators of early cortical somatosensory evoked potentials in the awake monkey | Q72237256 |
Nervous control of mammalian salivary glands | Q72660733 | ||
Streptozocin-induced diabetic rats: behavioural evidence for a model of chronic pain | Q72792853 | ||
Breath timing, volume and drive to breathe in conscious rats: comparative aspects | Q73292189 | ||
The merging of the senses: integration of subthreshold taste and smell | Q73685689 | ||
Reversible ageusia as an effect of clopidogrel treatment | Q73858333 | ||
Ageusia as an adverse effect of phenytoin treatment | Q74771145 | ||
Taste loss after phenytoin | Q77506839 | ||
Disorders of smell and taste | Q77934686 | ||
Molecular and physiological evidence for glutamate (umami) taste transduction via a G protein-coupled receptor | Q77939583 | ||
Anosmia as an adverse effect of dorzolamid | Q79787588 | ||
Tiered chemical testing: a value of information approach | Q81297747 | ||
Unfavorable smell with citalopram? | Q81304577 | ||
Parageusia in an epileptic child treated with lamotrigine | Q83022495 | ||
Olfactory and gustatory disturbances caused by digitalism: a case report | Q83858505 | ||
Clopidogrel-induced ageusia: a possible overlooked etiology by dentists? | Q84299856 | ||
Probable clindamycin-induced ageusia, xerostomia, and burning mouth syndrome | Q84525100 | ||
A study about the frequency of taste disorders | Q85118886 | ||
Comment: probable clindamycin-induced ageusia, xerostomia, and burning mouth syndrome | Q85205614 | ||
Loss of olfactory receptor genes coincides with the acquisition of full trichromatic vision in primates | Q21090246 | ||
Upregulation of barrel GABAergic neurons is associated with cross-modal plasticity in olfactory deficit | Q21562145 | ||
Human specific loss of olfactory receptor genes | Q22066323 | ||
Accumulating evidence supports a taste component for free fatty acids in humans | Q22337318 | ||
The human olfactory receptor gene family | Q24312045 | ||
Active vibrissal sensing in rodents and marsupials | Q24595453 | ||
Smelling sounds: olfactory-auditory sensory convergence in the olfactory tubercle. | Q24612023 | ||
Methods to identify and characterize developmental neurotoxicity for human health risk assessment. I: behavioral effects | Q24814115 | ||
Phosphodiesterase type 5 inhibitors and sudden sensorineural hearing loss | Q26824906 | ||
Recent advances in gut nutrient chemosensing | Q26830947 | ||
Toxic drug-induced hyposmia with lovastatin | Q28316562 | ||
Drug-Related Gustatory Disorders | Q28331562 | ||
Role of illness in producing learned taste aversions in rats: A comparison of several rodenticides | Q28341625 | ||
Learning with prolonged delay of reinforcement | Q29036236 | ||
The complete human olfactory subgenome | Q29618326 | ||
Disparities in auditory physiology and pathology between C57BL/6J and C57BL/6N substrains | Q30397222 | ||
Crossmodal reorganization in the early deaf switches sensory, but not behavioral roles of auditory cortex | Q30472775 | ||
Low-frequency tone pips elicit exaggerated startle reflexes in C57BL/6J mice with hearing loss | Q30473442 | ||
Topography and intracranial sources of somatosensory evoked potentials in the monkey. I. early components | Q39542728 | ||
Drugs affecting the inner ear. A review of their clinical efficacy, mechanisms of action, toxicity, and place in therapy | Q39557979 | ||
Sensory evoked potentials in neurotoxicology | Q39573871 | ||
An autoradiographic examination of the central distribution of the trigeminal, facial, glossopharyngeal, and vagal nerves in the monkey | Q39650063 | ||
A tier system for developmental toxicity evaluations based on considerations of exposure and effect relationships | Q39668037 | ||
Complexity of neurotoxicological assessment | Q39694314 | ||
Behavioral indices of neurotoxicity: what can be measured? | Q39694322 | ||
The use of sensory evoked potentials in toxicology | Q39818125 | ||
A tier system approach to mutagen testing | Q39944139 | ||
Behavioral pharmacology and toxicology | Q39980837 | ||
Neurobehavioral Techniques to Assess the Effects of Chemicals on the Nervous System | Q40179323 | ||
A neuromuscular screen for use in industrial toxicology | Q40243515 | ||
Behavioral toxicology in risk assessment: problems and research needs | Q40248799 | ||
Drug-induced taste and smell disorders. Incidence, mechanisms and management related primarily to treatment of sensory receptor dysfunction | Q40602615 | ||
Drug-induced tinnitus and other hearing disorders | Q40947010 | ||
Efficacy of low-dose intratympanic dexamethasone for sudden hearing loss | Q41335770 | ||
Current status of conducting function tests in repeated dose toxicity studies in Japan | Q41689077 | ||
Sequential, non-arteritic anterior ischemic optic neuropathy in patients taking sildenafil: a report of ten cases | Q41860984 | ||
Experimentally induced diabetes causes glial activation, glutamate toxicity and cellular damage leading to changes in motor function | Q42203606 | ||
Influenza vaccinations and chemosensory function | Q42225766 | ||
Neurological evaluation of toxic axonopathies in rats: acrylamide and 2,5-hexanedione | Q42681968 | ||
Ageusia associated to treatment with pregabalin | Q42728713 | ||
Ageusia as a side effect of clopidogrel treatment | Q42754475 | ||
Hypogeusia as an adverse reaction of phenytoin | Q42759391 | ||
Tonic modulation of spinal hyperexcitability by the endocannabinoid receptor system in a rat model of osteoarthritis pain | Q42791929 | ||
Characterisation of pain responses in the high fat diet/streptozotocin model of diabetes and the analgesic effects of antidiabetic treatments | Q43159888 | ||
Loss of taste and smell during treatment with topiramate | Q43236556 | ||
Recurrent dysosmia induced by pyrazinamide | Q43293080 | ||
Amygdaloid connections with posterior insular and temporal cortical areas in the rat. | Q43414266 | ||
Reversible ageusia induced by losartan: a case report | Q43977285 | ||
A simple, sensitive, and objective method for early assessment of acrylamide neuropathy in rats | Q44085685 | ||
Endogenous opioid peptide mediation of hypoalgesic response in long-term diabetic rats | Q44344067 | ||
Benchmarking safety pharmacology regulatory packages and best practice | Q44416908 | ||
Deafness induction in mice | Q44419423 | ||
A functional observational battery for use in canine toxicity studies: development and validation | Q44697277 | ||
Methylnaltrexone prevents morphine-induced kaolin intake in the rat. | Q44814120 | ||
Tactile allodynia and formalin hyperalgesia in streptozotocin-diabetic rats: effects of insulin, aldose reductase inhibition and lidocaine | Q45298501 | ||
Drug-related nephrotoxic and ototoxic reactions : a link through a predictive mechanistic commonality. | Q45402338 | ||
Influence of simultaneous gustatory stimuli on orthonasal and retronasal olfaction. | Q46018137 | ||
Reversible ageusia as an adverse effect of hydroxychloroquine treatment | Q46415693 | ||
Access of urinary nonvolatiles to the mammalian vomeronasal organ | Q46430891 | ||
A functional observational battery in non-human primates for regulatory-required neurobehavioral assessments | Q46513341 | ||
Objective assessment of terbinafine-induced taste loss | Q46829050 | ||
Safety assessment of high fructose corn syrup (HFCS) as an ingredient added to cigarette tobacco | Q46904112 | ||
Anosmia induced by amiodarone | Q46919654 | ||
Convergence of olfactory and gustatory connections onto the endopiriform nucleus in the rat. | Q47320043 | ||
A normative study of early prelingual auditory development | Q47626929 | ||
Speed and accuracy of olfactory discrimination in the rat | Q48169019 | ||
rTMS of the occipital cortex abolishes Braille reading and repetition priming in blind subjects | Q48260285 | ||
Encoding pheromonal signals in the accessory olfactory bulb of behaving mice | Q48383400 | ||
Taste pathways to hypothalamus and amygdala | Q48398736 | ||
Responses to taste stimulation in the ventroposteromedial nucleus of the thalamus in rats | Q48411496 | ||
Right-left asymmetries in the whisking behavior of rats anticipate head movements. | Q48434057 | ||
Discrimination of odors in olfactory bulb, pyriform-amygdaloid areas, and orbitofrontal cortex of the monkey | Q48444249 | ||
An olfactory projection area in orbitofrontal cortex of the monkey | Q48444255 | ||
Ibotenic acid lesions of the parabrachial nucleus and conditioned taste aversion: further evidence for an associative deficit in rats | Q48501573 | ||
Sir Charles Bell (1774-1842): contributions to neuro-ophthalmology. | Q48553612 | ||
Somatosensory evoked potentials (SEPs) and cortical single unit responses elicited by mechanical tactile stimuli in awake monkeys | Q48597782 | ||
Ascending central gustatory pathways | Q48643719 | ||
Reorganization of auditory cortex after neonatal high frequency cochlear hearing loss | Q48695162 | ||
Three-dimensional analysis of auditory-evoked potentials in rat neocortex. | Q48863306 | ||
The central projections of the trigeminal, facial, glossopharyngeal and vagus nerves: an autoradiographic study in the rat. | Q48875188 | ||
Synchrony between limbic system theta activity and rhythmical behavior in rats | Q48931410 | ||
Electrophysiological evidence for overlapping dominant and latent inputs to somatosensory cortex in squirrel monkeys. | Q50111668 | ||
THE ROLE OF AUDITORY CUES IN MODULATING THE PERCEIVED CRISPNESS AND STALENESS OF POTATO CHIPS | Q30473524 | ||
Cross-modal interactions of auditory and somatic inputs in the brainstem and midbrain and their imbalance in tinnitus and deafness | Q30484832 | ||
Comprehensive neurotoxicity assessment | Q30499989 | ||
Hearing loss raises excitability in the auditory cortex. | Q30501065 | ||
Incorporating new technologies into toxicity testing and risk assessment: moving from 21st century vision to a data-driven framework. | Q30662351 | ||
Vitamin E decreases valproic acid induced neural tube defects in mice | Q31444455 | ||
The olfactory system as a puzzle: playing with its pieces | Q33356271 | ||
Information processing in the mammalian olfactory system | Q33432678 | ||
Interactions of temperature and taste in conditioned aversions. | Q33693091 | ||
State dependence of olfactory perception as a function of taste cortical inactivation | Q33709883 | ||
Is Dysguesia Going to be a Rare or a Common Side-effect of Amlodipine? | Q33852741 | ||
Natural whisker-guided behavior by head-fixed mice in tactile virtual reality | Q33906572 | ||
Human vomeronasal organ function: a critical review of best and worst cases | Q33947831 | ||
The frequency of U-shaped dose responses in the toxicological literature | Q34083885 | ||
Gustatory dysfunction | Q34147372 | ||
Tactile acuity is enhanced in blindness. | Q34193084 | ||
U-shaped dose-responses in biology, toxicology, and public health | Q34198573 | ||
Could pesticide toxicology studies be more relevant to occupational risk assessment? | Q34210047 | ||
Pheromones': a new term for a class of biologically active substances | Q34245503 | ||
Effect of Fluoxetine on an Experimental Model of Diabetes-induced Neuropathic Pain Perception in the Rat. | Q34309087 | ||
Umami flavor enhances appetite but also increases satiety. | Q34425593 | ||
Intratympanic Therapies for Menière's disease | Q34438212 | ||
Ototoxic drugs: difference in sensitivity between mice and guinea pigs | Q34614937 | ||
Management of smell and taste problems. | Q34628086 | ||
Behavioral toxicology, risk assessment, and chlorinated hydrocarbons | Q34636669 | ||
A chemistry of mammalian pheromones | Q34657437 | ||
Cross-modal plasticity: where and how? | Q34664973 | ||
Alarm substance emitted by rats in the forced-swim test is a low volatile pheromone | Q34672095 | ||
Olfaction: anatomy, physiology, and disease | Q35052227 | ||
Pain mechanisms: a commentary on concepts and issues | Q35110248 | ||
The impact of cancer treatment on the diets and food preferences of patients receiving outpatient treatment | Q35158107 | ||
Molecular detection of pheromone signals in mammals: from genes to behaviour | Q35167947 | ||
Amygdalo-striatal interaction in the enhancement of stimulus salience in associative learning | Q35214186 | ||
Experimental Animal Models of Muscle Pain and Analgesia | Q35565418 | ||
Acute oxycodone induces the pro-emetic pica response in rats | Q35579493 | ||
Cross-modal regulation of synaptic AMPA receptors in primary sensory cortices by visual experience | Q35866951 | ||
In vitro models in endocrine disruptor screening | Q35904269 | ||
Dermal absorption of 2,4-D: a review of species differences | Q36009042 | ||
Predicting the risk of developmental toxicity from in vitro assays | Q36175511 | ||
The sniff as a unit of olfactory processing. | Q36336756 | ||
Neural correlates of sensory substitution in vestibular pathways following complete vestibular loss | Q36415859 | ||
The use of traditional toxicologic data in assessing neurobehavioral dysfunction | Q36448226 | ||
Rearing on hind legs, environmental novelty, and the hippocampal formation | Q36480368 | ||
A tiered approach to systemic toxicity testing for agricultural chemical safety assessment | Q36481766 | ||
Is neocortex essentially multisensory? | Q36483423 | ||
Conditioned gaping in rats: a selective measure of nausea | Q36584774 | ||
The mouse olfactory receptor gene family | Q36605181 | ||
Diabetic neuropathies: unanswered questions | Q36745975 | ||
Herophilus, Erasistratus, Aretaeus, and Galen: ancient roots of the Bell-Magendie Law. | Q36981597 | ||
Animal models of diabetic neuropathy: progress since 1960s | Q37100970 | ||
Multiple modes of network homeostasis in visual cortical layer 2/3. | Q37127176 | ||
The inverted "u-shaped" dose-effect relationships in learning and memory: modulation of arousal and consolidation | Q37426290 | ||
Functional assays for neurotoxicity testing | Q37809406 | ||
Intrinsic and therapeutic factors determining the recovery of motor function after peripheral nerve transection | Q37860487 | ||
Cell signaling mechanisms of gustatory perception of lipids: can the taste cells be the target of anti-obesity agents? | Q37897580 | ||
Behavioral indices of neurotoxicity | Q37940274 | ||
The amygdala and medial prefrontal cortex: partners in the fear circuit | Q38082742 | ||
Mechanisms and effects of "fat taste" in humans | Q38193001 | ||
Why fat is so preferable: from oral fat detection to inducing reward in the brain | Q38230948 | ||
Intratympanic steroid injection as a salvage treatment for sudden sensorineural hearing loss | Q38268520 | ||
The leptin-deficient (ob/ob) mouse: a new animal model of peripheral neuropathy of type 2 diabetes and obesity. | Q38307297 | ||
Learning and memory: Steroids and epigenetics | Q38376122 | ||
The nose smells what the eye sees: crossmodal visual facilitation of human olfactory perception | Q38427287 | ||
"Taste-smell confusions" and the duality of the olfactory sense | Q38499424 | ||
Serotonin as a mediator of cross-modal cortical reorganization | Q38577364 | ||
Is behavior or morphology a more sensitive indicator of central nervous system toxicity? | Q39139745 | ||
Phase of the theta wave in relation to different limb movements in awake rats | Q39470545 | ||
Quantitative sensory assessment in toxicology and occupational medicine: applications, theory, and critical appraisal | Q39530784 | ||
Intratympanic dexamethasone versus high dosage of betahistine in the treatment of intractable unilateral Meniere disease. | Q50353479 | ||
Auditory-olfactory integration: congruent or pleasant sounds amplify odor pleasantness. | Q50435597 | ||
Plasticity of frequency organization in auditory cortex of guinea pigs with partial unilateral deafness. | Q50558269 | ||
Travelling Waves as Frequency Analysers in the Cochlea | Q50653091 | ||
Reversal of neurobehavioral and neurochemical alterations in STZ-induced diabetic rats by FeTMPyP, a peroxynitrite decomposition catalyst and 1,5-Isoquinolinediol a poly(ADP-ribose) polymerase inhibitor. | Q50679885 | ||
Response to alarm substance in different rat strains. | Q51153165 | ||
Reversible ageusia associated with romidepsin therapy. | Q51173485 | ||
Anxiety, Stress, and the Contingent Negative Variation | Q51310258 | ||
Modification of electric activity in cochlear nucleus during attention in unanesthetized cats. | Q51332594 | ||
Taste function after stapes surgery. | Q51360913 | ||
Auditory brainstem response in sheep. Part II: Postnatal development. | Q52203833 | ||
Functional relations between the cortical gustatory area and the amygdala: electrophysiological and behavioral studies in rats. | Q52213065 | ||
Taste responses of cortical neurons in freely ingesting rats. | Q52246142 | ||
A quantitative analysis of sniffing strategies in rats performing odor detection tasks. | Q52258174 | ||
Pica: A species relevant behavioral assay of motion sickness in the rat | Q52307904 | ||
International validation of a neurobehavioral screening battery: the IPCS/WHO collaborative study | Q52409127 | ||
Intratympanic steroid injection for Bell's palsy: preliminary randomized controlled study. | Q53264888 | ||
Aspects of the history of the nerves: Bell's theory, the Bell-Magendie law and controversy, and two forgotten works by P.W. Lund and D.F. Eschricht. | Q53364931 | ||
Effect of Hyperglycemia on Pain Perception and on Efficacy of Morphine Analgesia in Rats | Q54377021 | ||
Use of pharmacological screening tests in subacute neurotoxicity studies of isoniazid, pyridoxine HCl and hexachlorophene. | Q54568948 | ||
Receptor seeks ligand: on the way to cloning the molecular receptors for sweet and bitter taste. | Q55032964 | ||
Reversible ageusia associated with losartan | Q56832849 | ||
Analysis of Sniffing of the Albino Rat 1) | Q56865887 | ||
Multicenter Study of Subjective Acceptance During Magnetic Resonance Imaging at 7 and 9.4 T | Q57603611 | ||
Subjective and Objective Olfactory Abnormalities in Crohn's disease | Q57779840 | ||
Early-blind human subjects localize sound sources better than sighted subjects | Q59071832 | ||
Pica—A model of nausea? Species differences in response to cisplatin | Q61694390 | ||
Loss of taste and terbinafine | Q67517289 | ||
Poison induced pica in rats | Q68292833 | ||
Thermal sensitivity of neurons in a rostral part of the rat solitary tract nucleus | Q68483988 | ||
Surface distribution of flash-evoked and pattern reversal-evoked potentials in hooded rats | Q68984825 | ||
Disposition of 2,4-dichlorophenoxyacetic acid dimethylamine by Fischer 344 rats dosed orally and dermally | Q69755393 | ||
2,4-Dichlorophenoxyacetic acid (2,4-D) does not cause polyneuropathy in the rat | Q70106429 | ||
Some like it hot: a temporal analysis of hedonic responses to chili pepper | Q70421557 | ||
Some aspects of the liking for hot coffee and coffee flavor | Q70421560 | ||
Rifabutin-induced ageusia | Q70460175 | ||
A quantitative comparison of motor and sensory conduction velocities in short- and long-term streptozotocin- and alloxan-diabetic rats | Q70532693 | ||
Nerve conduction velocity studies of workers employed in the manufacture of phenoxy herbicides | Q70562361 | ||
Studies on gustatory responses of amygdaloid neurons in rats | Q70586693 | ||
Taste and olfaction: independence vs interaction | Q71196753 | ||
Case of ageusia from a variety of causes | Q71415543 | ||
A transthalamic olfactory pathway to orbitofrontal cortex in the monkey | Q71492749 | ||
Alcohol Aversion in the Rat: Behavioral Assessment of Noxious Drug Effects | Q71508543 | ||
The role of congruency and pleasantness in odor-induced taste enhancement | Q71714326 | ||
Auditory brainstem response in sheep. Part I: Fetal development | Q72053178 | ||
Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse | Q72110918 | ||
Gustatory, olfactory, and visual convergence within the primate orbitofrontal cortex | Q72182860 | ||
P304 | page(s) | 53-74 | |
P577 | publication date | 2015-06-02 | |
P1433 | published in | Journal of Pharmacological and Toxicological Methods | Q15724529 |
P1476 | title | The failure to detect drug-induced sensory loss in standard preclinical studies | |
P478 | volume | 74 |
Q48454566 | 15th Annual Meeting of the Safety Pharmacology Society: Focus on traditional sensory systems |
Q88641890 | A predictive index of biomarkers for ictogenesis from tier I safety pharmacology testing that may warrant tier II EEG studies |
Q49356760 | Causality Assessment of Olfactory and Gustatory Dysfunction Associated with Intranasal Fluticasone Propionate: Application of the Bradford Hill Criteria. |
Q50013708 | Down for the count: The critical endpoint in ototoxicity remains the cytocochleogram. |
Q39143233 | Repeated "Day 1" FOB testing in ICH S7A safety assessment protocols: The influence of within- and between-session learning |
Q38838058 | Small Compartment Toxicity: CN VIII and Quality of Life: Hearing Loss, Tinnitus, and Balance Disorders |
Q38930182 | The standardized functional observational battery: Its intrinsic value remains in the instrument of measure: The rat. |
Search more.